Prime Medicine Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.
/ 
Frequently asked questions
To buy Prime Medicine Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Prime Medicine Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Prime Medicine Inc. is PRME:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Prime Medicine Inc. has its primary listing on NASDAQ. You can trade Prime Medicine Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Prime Medicine Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Prime Medicine Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Prime Medicine Inc..